Urinary and plasma levels of vasohibin-1 can predict renal functional deterioration in patients with renal disorders.

Urinary and plasma levels of vasohibin-1 can predict renal functional deterioration in patients with renal disorders.
复制标题

DOI:
10.1371/journal.pone.0096932
复制
发表时间:
2014
期刊:
影响因子:
3.7
通讯作者:
Makino H
Makino H
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Hinamoto N;Maeshima Y;Saito D;Yamasaki H;Tanabe K;Nasu T;Watatani H;Ujike H;Kinomura M;Sugiyama H;Sonoda H;Sato Y;Makino H

文献摘要

参考文献

被引文献

相似文献

血管收缩素-1(VASH-1)是血管生成的负反馈调节因子,小分子血管收缩素结合蛋白(SVBP)作为其分泌伴侣参与其抗血管生成作用。在本研究中,我们的目的是确定VASH-1和SVBP在慢性肾脏病(CKD)患者中的临床意义。我们招募了67名日本住院的肾脏疾病患者(n = 45)或无(n = 22)肾活检样本和10名日本健康对照。    我们评估了血浆和尿液中VASH-1/VASH-1-SVBP复合物/SVBP水平与临床病理参数之间的相关性。血浆VASH-1水平与年龄、收缩压和舒张压呈负相关,与新月体形成呈正相关。血浆和尿液中VASH-1和VASH-1-SVBP复合物水平升高与肾脏预后不良显著相关。这些结果表明尿和血浆VASH-1水平升高与肾功能进行性下降之间存在相关性,从而表明VASH-1在预测肾病(包括CKD)患者的肾脏预后不良方面具有潜在作用。
Vasohibin-1 (VASH-1) is a negative feedback regulator of angiogenesis, and a small vasohibin-binding protein (SVBP) serves as its secretory chaperone and contributes to its antiangiogenic effects. In the present study, we aimed to define the clinical significance of VASH-1 and SVBP in patients with chronic kidney disease (CKD). We recruited 67 Japanese hospitalized patients with renal disorders with (n = 45) or without (n = 22) renal biopsy samples and 10 Japanese healthy controls. We evaluated the correlations between the plasma and urinary levels of VASH-1/VASH-1-SVBP complex/SVBP and the clinicopathological parameters. The plasma levels of VASH-1 were inversely correlated with age and systolic and diastolic blood pressure and positively correlated with crescent formation. Increased plasma and urinary levels of VASH-1 and VASH-1-SVBP complex were significantly correlated with worse renal outcomes. These results demonstrate an association between elevated urinary and plasma levels of VASH-1 and progressive decline of the renal function, thus suggesting a potential role for VASH-1 in predicting a worse renal prognosis in patients with renal disease, including CKD.
DOI: 10.1093/ndt/gfq200
发表时间: 2010-10-01
影响因子: 6.1
作者:
Hohenstein, Bernd;Colin, Maite;Hugo, Christian P. M.
通讯作者: Hugo, Christian P. M.
DOI: 10.2353/ajpath.2009.080788
发表时间: 2009-07-01
影响因子: 6
作者:
Hosaka, Tomoko;Kimura, Hiroshi;Sato, Yasufumi
通讯作者: Sato, Yasufumi
DOI: 10.1093/ndt/gfp315
发表时间: 2009-11-01
影响因子: 6.1
作者:
Guo, Qunying;Carrero, Juan Jesus;Axelsson, Jonas
通讯作者: Axelsson, Jonas
DOI: 10.2337/diabetes.51.10.3090
发表时间: 2002-10-01
期刊: DIABETES
影响因子: 7.7
作者:
Flyvbjerg, A;Dagnæs-Hansen, F;Rasch, R
通讯作者: Rasch, R
DOI: 10.1038/sj.ki.5000439
发表时间: 2006-06-01
影响因子: 19.6
作者:
Hara, A.;Wada, T.;Kaneko, S.
通讯作者: Kaneko, S.